Nisa Investment Advisors, LLC Karuna Therapeutics, Inc. Transaction History

Nisa Investment Advisors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 25, 2024	SELL	$161.01 - $317.85 $42,667 - $84,230	-265 Reduced 49.07%	275 $87,000
Q3 2023 Nov 02, 2023	SELL	$164.66 - $218.08 $1.4 Million - $1.85 Million	-8,488 Reduced 94.02%	540 $91,000
Q2 2023 Aug 11, 2023	BUY	$176.32 - $240.22 $1.45 Million - $1.98 Million	8,223 Added 1021.49%	9,028 $1.96 Million
Q1 2023 May 02, 2023	BUY	$161.33 - $204.36 $1,613 - $2,043	10 Added 1.26%	805 $146,000
Q3 2022 Nov 07, 2022	BUY	$123.79 - $277.42 $3,589 - $8,045	29 Added 3.79%	795 $174,000

Q2 2022 Aug 03, 2022	BUY	$93.97 - $143.33 $7,517 - $11,466	80 Added 11.66%	766 $97,000
Q1 2022 Apr 29, 2022	SELL	$98.9 - $132.37 $54,988 - $73,597	-556 Reduced 44.77%	686 $87,000
Q4 2021 Feb 03, 2022	BUY	$110.64 - $159.4 $24,008 - $34,589	217 Added 21.17%	1,242 $138,000
Q3 2021 Oct 18, 2021	BUY	$101.2 - $125.87 $7,590 - $9,440	75 Added 7.89%	1,025 $125,000
Q4 2020 Jan 25, 2021	BUY	$75.23 - $109.23 $22,569 - $32,769	300 Added 46.15%	950 $97,000
Q3 2020 Oct 20, 2020	BUY	$71.31 - $109.74 $46,351 - $71,331	650 New	650 $50,000

333K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Nisa Investment Advisors, LLC with notifications on news.